Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

SureClinical Announces Support for OASIS eTMF Draft Specification
  • USA - English


News provided by

SureClinical Inc

Jun 26, 2014, 13:10 ET

Share this article

Share toX

Share this article

Share toX


Rancho Cordova, CA (PRWEB) June 26, 2014 -- On June 25th, the global clinical trials industry took a step toward global clinical trial data standardization with the publication of the OASIS eTMF Committee Specification Draft V1.0 for clinical trial regulated content management interoperability.

"SureClinical congratulates the OASIS eTMF Standard Technical Committee members who participated in the development of this important specification." --Zachariah Schmidt, SureClinical CEO

Post this

Designed as a standard based upon standards, the OASIS eTMF Specification is designed to facilitate information exchange between clinical trial systems through standard web-based technologies, a controlled vocabulary and a published taxonomy for the clinical trials domain. The OASIS eTMF Specification promises to accelerate clinical trials processes, and will move the industry from manual, paper-based processes to automated fully 100% digital operations. OASIS is a non-profit, international consortium that drives the development, convergence and adoption of open standards. The OASIS consortium has more than 5,000 participants representing over 600 organizations and individual members in 100 countries. Global document system vendor organizations such as Alfresco, EMC, IBM, Microsoft, Oracle and many others are contributors to OASIS and members of OASIS, demonstrating the long-term commitment vendors have made toward interoperable systems and data portability.

To ensure that data is portable between document management systems, the OASIS eTMF Specification utilizes a web standard technology known as RDF/XML. In much the same way that the HTML language is used as the basis for the browsing of internet content through any web browser from multiple browser vendors, RDF/XML is used to publish clinical trial content that can be shared across systems and networks.    RDF-based technologies, also known as ‘linked data,’ are being adopted by a broad group of BioPharma organizations. CDISC, FDA/PhUSE and National Cancer Institute and others involved in BioInformatic systems development are using RDF-based linked data technologies to facilitate interoperability. With the OASIS eTMF Standard Technical Committee’s adoption of RDF/XML as the standard for eTMF content and record sharing, BioPharma companies will be able to seamlessly exchange regulated documents with a variety of clinical systems saving invaluable time from study-startup through completion.

In the eTMF systems area, SureClinical is the first eTMF applications software vendor to announce compliance with the draft eTMF specification. With its native support for RDF/XML technologies, as well as integrated eTMF application design, taxonomy and metadata editing, integrated high-trust digital signing and clinical trial workflow automation, SureClinical provides customers with a powerful suite of standards-based tools and capabilities that maximizes productivity, quality and compliance throughout all stages of a clinical trial. SureClinical’s cloud-based platform enables users to export, import or exchange structured content between any vendor application that has RDF/XML support, thereby protecting customers from vendor lock-in. To ensure interoperability and data portability, SureClinical’s integrated eTMF application taxonomy designer automatically displays metadata terms sourced from published controlled vocabulary repositories such as the National Cancer Institutes’ NCI Thesaurus. SureClinical can support display of application terms in any language through its use of localized term display labels.

The controlled vocabulary used in the OASIS eTMF Specification was recently published by the National Cancer Institute’s Enterprise Vocabulary Services (NCI) and is available online at the NCI Thesaurus term repository at http://ncit.nci.nih.gov/. NCI Thesaurus is a public term repository used by life science and health care standards globally in systems development.    The eTMF Specification Version 1.0 incorporates global technical standards and controlled terms developed by BRIDG (CDISC/FDA/HL7), CareLex, Dublin Core, HL7, National Cancer Institute, the TMF Reference Model, and W3C. NCI Thesaurus repository terms are used by organizations globally such as FDA, CDISC, HL7, ICD-10, SNOMED, WHO and many others as a repository and resource for open source controlled vocabulary development. NCI Thesaurus is an open organization that ensures term consistency and interoperability across domains, and participation and use of the terms are open to anyone worldwide.

Supporting Quote
“SureClinical congratulates the OASIS eTMF Standard Technical Committee members who participated in the development of this important specification, and welcomes the benefits that it will offer all sponsors, research organizations, vendors and stakeholders involved in clinical trial regulated content management,” said Zachariah Schmidt, SureClinical’s CEO.

OASIS eTMF Standard Draft Specification Download
As part of the eTMF standardization effort toward a global ISO standard for clinical trial data exchange, the OASIS eTMF Standard TC will seek public review and comment on its recent draft publication which is available as a package for free download from OASIS at: https://www.OASIS-open.org/news/announcements/45-day-public-review-for-electronic-trial-master-file-etmf-specification-version-

Comments and Public Contributions Welcome
All interested parties are welcome to contribute or comment on the draft OASIS eTMF Standard specification. Additional information is available through OASIS at: https://www.OASIS-open.org/committees/etmf

For additional details on how the OASIS eTMF Specification can help minimize risk in your clinical trial operations, see the FAQ: http://www.sureclinical.com/oasis-etmf-standard-faq/

About SureClinical
Headquartered in Northern California, SureClinical is the premier provider of health science content management software applications for life sciences and healthcare markets. SureClinical’s health science content management solutions enable organizations to eliminate paper through patented integrated high-trust digital signing and automated clinical trial workflows.

SureClinical Cloud Certifications
The technology infrastructure underlying the SureClinical Certified Cloud provides customers with the most comprehensive list of government regulatory validations and certifications in the industry, as well as the infrastructure to support extreme performance, scalability, availability and security needed to run mission-critical, health science specific solutions:

SSAE-16 Type I and Type II Attestation: Support for both SSAE-16 Type I and Type II attestations in conjunction with auditor SSAE 16 Solutions.

HIPAA Business Associate: SureClinical maintains policies and procedures necessary to act as a HIPAA Business Associate for customers whose application maintains data covered by HIPAA regulations.

FDA CFR Part 11 Application Certification: SureClinical’s SureTrial eTMF cloud application is independently audited and validated through an ongoing program of continuous validation and certification. These in-depth evaluations of our cloud applications and cloud infrastructure are done against a rigorous set of FDA regulations.

U.S. Commerce Department Safe Harbor Certification: SureClinical’s cloud is certified under the U.S Commerce Department’s Safe Harbor program, which signifies that the SureClinical cloud employs policies and procedures that meet the privacy standards of the European Commission's Directive on Data Protection. By certifying under the program, SureClinical’s customers can be assured that their personal information is private and protected.

For more information, visit http://www.SureClinical.com.

Copyright © 2014 SureClinical. All rights reserved. SureClinical, SureEsign, SureTrial, and the SureTrial logo are trademarks of SureClinical. Other names used herein may be trademarks of their respective owners.

#

Zack Schmidt, SureClinical Inc, 916-265-2000, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.